Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome

Abstract

Copyright © 2015 by the American Thoracic Society. Based on preclinical data, cell-based therapy with bone marrow-derived mesenchymal stem cells is a potentially attractive new therapeutic option for treating patients with the acute respiratory distress syndrome. Small and large animal models of acute lung injury from endotoxin, live bacteria, and sepsis have shown that MSCs can decrease lung injury and increase survival. The mechanisms for benefit are mediated in part by paracrine release of several antiinfl ammatory cytokines, keratinocyte growth factor, angiopoietin-1, as well as the release of antimicrobial peptides. There is also evidence that MSCs can transfer mitochondria and restore normal bioenergetics to injured alveolar epithelium. Some of the beneficial effects are mediated by microvesicles. A phase 1 safety and dose-escalation trial was completed and a randomized, double-blind clinical trial is currently underway.

Categories

Add categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

  • Only published works are available at libraries.

My notes

Similar books and articles

Mesenchymal stem cells: Mechanisms of potential therapeutic benefit in ARDS and sepsis.J. Walter, L. B. Ware & M. A. Matthay - unknown
Human mesenchymal stem cells promote the resolution of acute lung injury in part through lipoxin A4.X. Fang, J. Abbott, L. Cheng, J. K. Colby, J. W. Lee, B. D. Levy & M. A. Matthay - unknown
Design and implementation of the START trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. [REVIEW]K. D. Liu, J. G. Wilson, H. Zhuo, L. Caballero, M. L. McMillan, X. Fang, K. Cosgrove, C. S. Calfee, J. W. Lee, K. N. Kangelaris, J. E. Gotts, A. J. Rogers, J. E. Levitt, J. P. Wiener-Kronish, K. L. Delucchi, A. D. Leavitt, D. H. McKenna, B. T. Thompson & M. A. Matthay - unknown
Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice.A. Monsel, Y. G. Zhu, S. Gennai, Q. Hao, S. Hu, J. J. Rouby, M. Rosenzwajg, M. A. Matthay & J. W. Lee - unknown
Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.S. Gennai, A. Monsel, Q. Hao, J. Park, M. A. Matthay & J. W. Lee - unknown
Volume delivered during recruitment maneuver predicts lung stress in acute respiratory distress syndrome. Beitler Jr, R. Majumdar, R. D. Hubmayr, A. Malhotra, B. T. Thompson, R. L. Owens, S. H. Loring & D. Talmor - unknown
Unexpected role for adaptive αβTh17 cells in acute respiratory distress syndrome.J. T. Li, A. C. Melton, G. Su, M. de HammLa Femina, J. Howard, X. Fang, S. Bhat, K. M. Huynh, C. M. O'Kane, R. J. Ingram, R. R. Muir, D. F. McAuley, M. A. Matthay & D. Sheppard - unknown
Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?Susan M. Millard & Nicholas M. Fisk - 2013 - Bioessays 35 (3):173-182.
Estimating dead-space fraction for secondary analyses of acute respiratory distress syndrome clinical trials.Jeremy R. Beitler, B. Taylor Thompson, Michael A. Matthay, Daniel Talmor, Kathleen D. Liu, Hanjing Zhuo, Douglas Hayden, Roger G. Spragg & Atul Malhotra - unknown
Mechanical ventilation in acute hypoxemic respiratory failure: A review of new strategies for the practicing hospitalist. [REVIEW]J. G. Wilson & M. A. Matthay - unknown
The place of pleasure in Aristotle's ethics.Amelie Oksenberg Rorty - 1974 - Mind 83 (332):481-497.
Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials.C. S. Calfee, K. Delucchi, P. E. Parsons, B. T. Thompson, L. B. Ware & M. A. Matthay - unknown
Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome.C. K. Grissom, E. L. Hirshberg, J. B. Dickerson, S. M. Brown, M. J. Lanspa, K. D. Liu, D. Schoenfeld, M. Tidswell, R. D. Hite, P. Rock, R. R. Miller, A. H. Morris, L. Hudson, S. Gundel, C. Hough, M. Neff, K. Sims, A. Ungar, T. Watkins, J. Steingrub, E. Braden, L. DeSouza, J. Germain, C. Kardos, D. Kelley, L. Kozikowski, S. Ouellette, K. Guntupalli, V. Bandi, C. Pope, C. Ross, R. Brower, H. Fessler, D. Hager, P. Mendez-Tellez, D. Needham, K. Oakjones, J. Sevransky, A. Workneh, C. Shanholtz, D. Herr, H. Howes, G. Netzer, A. Sampaio, J. Titus, P. Sloane, T. Beck, H. Highfield, S. King, B. Lee, N. Bolouri, H. P. Wiedemann, R. W. Ashton, T. da CulverFrederick, J. A. Guzman, J. J. Komara, A. J. Reddy, R. Hejal, M. Andrews, D. Haney, A. F. Connors, S. Lasalvia, J. D. Thornton, E. L. Warren, M. Moss, E. L. Burnham, L. Gray, J. Maloney, M. Mealer, I. Douglas, K. Overdier, K. Thompson, R. Wolken, S. Frankel, J. McKeehan, M. L. Warner, T. Bost, C. Higgins, K. Hodgin, N. MacIntyre, L. Brown, C. Cox, M. Gentile, J. Govert, N. Knudsen, S. Carson, L. Chang & S. Choudhury - unknown
Therapeutic cloning: The ethical limits.Peter Whittaker - 2005 - .
‘No Time to be Lost!’: Ethical Considerations on Consent for Inclusion in Emergency Pharmacological Research in Severe Traumatic Brain Injury in the European Union.Erwin J. O. Kompanje - 2007 - Science and Engineering Ethics 13 (3):371-381.

Analytics

Added to PP
2017-03-08

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references